Search the Appendices of Resolution CM/Res(2018)1
1721 found
INN | ATC Code ▲ | Country | Classification | Last update | MA Number | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
APALUTAMIDE | L02BB05 | RS | POM | 07-05-2019 | VALID | |||
DAROLUTAMIDE | L02BB06 | RS | Not authorised | 07-10-2020 | VALID | |||
ABIRATERONE | L02BX03 | RS | POM | VALID | ||||
RELUGOLIX | L02BX04 | RS | Not authorised | 23-11-2022 | VALID | |||
FILGRASTIM | L03AA02 | RS | POM | VALID | ||||
PEGFILGRASTIM | L03AA13 | RS | POM | VALID | ||||
LIPEGFILGRASTIM | L03AA14 | RS | POM | VALID | ||||
ROPEGINTERFERON ALFA-2B | L03AB15 | RS | Not authorised | VALID | ||||
ALDESLEUKIN | L03AC01 | RS | Not authorised | VALID | ||||
LENTINAN | L03AX01 | RS | Not authorised | VALID | ||||
ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) | L04AA04 | RS | POM | VALID | ||||
ABATACEPT | L04AA24 | RS | Not authorised | VALID | ||||
CLADRIBINE | L04AA40 | RS | POM | VALID | ||||
IMLIFIDASE | L04AA41 | RS | Not authorised | 07-10-2020 | VALID | |||
EFGARTIGIMOD ALFA | L04AA58 | RS | Not authorised | 23-11-2022 | VALID | |||
ETANERCEPT | L04AB01 | RS | POM | VALID | ||||
INFLIXIMAB | L04AB02 | RS | POM | VALID | ||||
ADALIMUMAB | L04AB04 | RS | POM | VALID | ||||
CERTOLIZUMAB PEGOL | L04AB05 | RS | Not authorised | VALID | ||||
GOLIMUMAB | L04AB06 | RS | POM | VALID | ||||
DACLIZUMAB | L04AC01 | RS | Not authorised | VALID | ||||
ANAKINRA | L04AC03 | RS | Not authorised | VALID | ||||
SECUKINUMAB | L04AC10 | RS | POM | VALID | ||||
BRODALUMAB | L04AC12 | RS | Not authorised | 06-11-2017 | VALID | |||
IXEKIZUMAB | L04AC13 | RS | Not authorised | 21-11-2016 | VALID | |||
SARILUMAB | L04AC14 | RS | Not authorised | 06-11-2017 | VALID | |||
GUSELKUMAB | L04AC16 | RS | POM | 29-03-2018 | EMEA/H/C/004271 | 15-11-2017 | VALID | |
TILDRAKIZUMAB | L04AC17 | RS | Not authorised | 12-11-2018 | VALID | |||
RISANKIZUMAB | L04AC18 | RS | Not authorised | VALID | ||||
SATRALIZUMAB | L04AC19 | RS | Not authorised | 12-10-2021 | VALID | |||
BIMEKIZUMAB | L04AC21 | RS | Not authorised | 12-10-2021 | VALID | |||
SPESOLIMAB | L04AC22 | RS | Not authorised | VALID | ||||
MIRIKIZUMAB | L04AC24 | RS | Not authorised | 20-11-2023 | VALID | |||
CICLOSPORIN | L04AD01 | RS | POM | VALID | ||||
TACROLIMUS | L04AD02 | RS | POM | VALID | ||||
VOCLOSPORIN | L04AD03 | RS | Not authorised | 23-11-2022 | VALID | |||
FINGOLIMOD | L04AE01 | RS | POM | VALID | ||||
OZANIMOD | L04AE02 | RS | Not authorised | 07-10-2020 | VALID | |||
SIPONIMOD | L04AE03 | RS | Not authorised | 23-04-2020 | VALID | |||
PONESIMOD | L04AE04 | RS | Not authorised | 12-10-2021 | VALID | |||
ETRASIMOD | L04AE05 | RS | Not authorised | 13-05-2024 | VALID | |||
TOFACITINIB | L04AF01 | RS | POM | VALID | ||||
BARICITINIB | L04AF02 | RS | Not authorised | 29-05-2017 | VALID | |||
UPADACITINIB | L04AF03 | RS | Not authorised | 23-04-2020 | VALID | |||
FILGOTINIB | L04AF04 | RS | Not authorised | 02-06-2021 | VALID | |||
DEUCRAVACITINIB | L04AF07 | RS | Not authorised | VALID | ||||
RITLECITINIB | L04AF08 | RS | Not authorised | 20-11-2023 | VALID | |||
NATALIZUMAB | L04AG03 | RS | POM | 25-10-2017 | VALID | |||
BELIMUMAB | L04AG04 | RS | POM | VALID | ||||
ALEMTUZUMAB | L04AG06 | RS | POM | VALID |